India  

Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results

Video Credit: CBS 3 Philly - Duration: 00:53s - Published
Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results

Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results

The company says it hopes to get data supporting the effectiveness of its COVID-19 vaccine early next year.

0
shares
ShareTweetSavePostSend
 

AND WE'LL HAVE A LINK TO ITALL ON OUR WEB SITECBSPHILLY.COM.TODAY PLYMOUTH MEETINGBASED COMPANY INOVAPHARMACEUTICALS ANNOUNCEDPOSITIVE RESULTS FROM EARLYSTAGE TESTING OF ITS COVID-19VACCINE.BUT OFFICIALS WITH THEBIOTECHNOLOGY COMPANY DID NOTDISCLOSE COMPLETE DATA ANDTHAT SENT SHARES OF THECOMPANY'S STOCK TUMBLING ONWALL STREET.WE SPOKE WITH INOVA'S CEOTODAY AND HE EXPLAINS THEVACCINE TESTING RESULTS.SIX WEEKS AGO 36 PEOPLERECEIVED TWO INJECTIONS.EARLY PHASE ONE CLINICALTRIALS ON COVID-19 VACCINETHAT INOVA'S DEVELOPDEMONSTRATED A VERY STRONGSAFETY AND VERY EARLY BUT VERYPROMISING IMMUNE RESPONSESFROM THE TRIAL.INOVA SAYS 94% OF THE TRIALPARTICIPANTS DEMONSTRATEDOVERALL IMMUNE RESPONSES.THE COMPANY SAYS IT HOPES TO




You Might Like


Tweets about this


Related videos from verified sources

Evansville Man Speaks After Testing Positive for COVID-19 [Video]

Evansville Man Speaks After Testing Positive for COVID-19

After learning the results of his COVID-19 test was "positive," one Evansville man has been in quarantine ever since.

Credit: WEVVPublished
Brazil's President Bolsonaro Tests Positive for Coronavirus [Video]

Brazil's President Bolsonaro Tests Positive for Coronavirus

Bolsonaro announced his test results himself via Brazilian television on Tuesday.

Credit: Cover Video STUDIO     Duration: 01:14Published
U.S. hands Novavax $1.6b to work on COVID-19 vaccine [Video]

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30 percent. Conway G. Gittens has more.

Credit: Reuters Studio     Duration: 02:12Published